Zura Bio Ltd cotiza a 4.23 USD y tiene una capitalización bursátil de $405M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therap…
| Periodo | 2026-11 | 2026-08 | 2026-08 | 2026-05 |
|---|---|---|---|---|
| Real | — | — | $-0.21 | $-0.22 |
| Estimado | $-0.21 | $-0.19 | $-0.19 | $-0.18 |
| Sorpresa | — | — | -10.5% | -22.2% |
| Métrica | ZURA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -67.6% | -40.4% | -27.2% |
| ROA | -60.3% | -32.0% | -28.2% |
| Current Ratio | 9.05 | 2.84 | +6.21 |
| Debt / Equity | — | 0.28 | — |